OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential
Danyi Yang, Man J. Livingston, Zhiwen Liu, et al.
Cellular and Molecular Life Sciences (2017) Vol. 75, Iss. 4, pp. 669-688
Open Access | Times Cited: 211

Showing 1-25 of 211 citing articles:

Autophagy in kidney homeostasis and disease
Chengyuan Tang, Man J. Livingston, Zhiwen Liu, et al.
Nature Reviews Nephrology (2020) Vol. 16, Iss. 9, pp. 489-508
Open Access | Times Cited: 361

The tubular hypothesis of nephron filtration and diabetic kidney disease
Volker Vallon, Scott C. Thomson
Nature Reviews Nephrology (2020) Vol. 16, Iss. 6, pp. 317-336
Open Access | Times Cited: 319

Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway
Huiwen Ren, Ying Shao, Can Wu, et al.
Molecular and Cellular Endocrinology (2019) Vol. 500, pp. 110628-110628
Closed Access | Times Cited: 248

p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease
Zhengwei Ma, Li Lin, Man J. Livingston, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 9, pp. 5011-5026
Open Access | Times Cited: 153

Mechanisms of podocyte injury and implications for diabetic nephropathy
Federica Barutta, Stefania Bellini, Gabriella Gruden
Clinical Science (2022) Vol. 136, Iss. 7, pp. 493-520
Open Access | Times Cited: 115

Diabetic nephropathy: Focusing on pathological signals, clinical treatment, and dietary regulation
Qichao Hu, Yuan Chen, Xinyu Deng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114252-114252
Open Access | Times Cited: 99

Rutin alleviates EndMT by restoring autophagy through inhibiting HDAC1 via PI3K/AKT/mTOR pathway in diabetic kidney disease
Ruixue Dong, Xi Zhang, Yadi Liu, et al.
Phytomedicine (2023) Vol. 112, pp. 154700-154700
Closed Access | Times Cited: 43

Crosstalk among podocytes, glomerular endothelial cells and mesangial cells in diabetic kidney disease: an updated review
Shiwan Hu, Hang Xing, Yu Wei, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 23

Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets
Jonatan Barrera‐Chimal, Frédéric Jaisser
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. S1, pp. 16-31
Open Access | Times Cited: 129

The New Biology of Diabetic Kidney Disease—Mechanisms and Therapeutic Implications
Yuliya Lytvyn, Petter Bjornstad, Daniël H. van Raalte, et al.
Endocrine Reviews (2019) Vol. 41, Iss. 2, pp. 202-231
Open Access | Times Cited: 113

Transforming Growth Factor-Beta1 in Diabetic Kidney Disease
Lijun Zhao, Yutong Zou, Fang Liu
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 112

Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease
Xue-qi Liu, Ling Jiang, Yuanyuan Li, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 1, pp. 96-110
Open Access | Times Cited: 97

Molecular Interactions Between Reactive Oxygen Species and Autophagy in Kidney Disease
Gur P. Kaushal, Kiran Chandrashekar, Luis A. Juncos
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 15, pp. 3791-3791
Open Access | Times Cited: 95

AMPK/mTOR Signaling in Autophagy Regulation During Cisplatin-Induced Acute Kidney Injury
Ying Wang, Zhiwen Liu, Shaoqun Shu, et al.
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 92

SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes
Anton I. Korbut, Iuliia Taskaeva, Н. П. Бгатова, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2987-2987
Open Access | Times Cited: 88

METTL14 aggravates podocyte injury and glomerulopathy progression through N6-methyladenosine-dependent downregulating of Sirt1
Zhihui Lu, Hong Liu, Nana Song, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 10
Open Access | Times Cited: 86

Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy
Yingfeng Shi, Min Tao, Xiaoyan Ma, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 6
Open Access | Times Cited: 83

Autophagy in diabetic nephropathy: a review
Elias A. T. Koch, Rola Nakhoul, Farid Nakhoul, et al.
International Urology and Nephrology (2020) Vol. 52, Iss. 9, pp. 1705-1712
Closed Access | Times Cited: 83

Autophagy Function and Regulation in Kidney Disease
Gur P. Kaushal, Kiran Chandrashekar, Luis A. Juncos, et al.
Biomolecules (2020) Vol. 10, Iss. 1, pp. 100-100
Open Access | Times Cited: 82

Proximal Tubule Autophagy Differs in Type 1 and 2 Diabetes
Shinsuke Sakai, Takeshi Yamamoto, Yoshitsugu Takabatake, et al.
Journal of the American Society of Nephrology (2019) Vol. 30, Iss. 6, pp. 929-945
Open Access | Times Cited: 78

SMAD3 promotes autophagy dysregulation by triggering lysosome depletion in tubular epithelial cells in diabetic nephropathy
Chen Yang, Xiaocui Chen, Zhihang Li, et al.
Autophagy (2020) Vol. 17, Iss. 9, pp. 2325-2344
Open Access | Times Cited: 76

Glucose Variability: How Does It Work?
Vadim V. Klimontov, Olga Saik, Anton I. Korbut
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7783-7783
Open Access | Times Cited: 73

Page 1 - Next Page

Scroll to top